Indian pharma giant Dr. Reddy’s Laboratories Ltd. says Health Canada has rejected its application to make generic semaglutide, a setback for what was poised to be one of the first generic competitors ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer cheaper generic versions of medications like Ozempic and Wegovy to people with ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a generic version of liraglutide manufactured by Hikma ...

Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada as Novo Nordisk loses patent protection. Novo Nordisk will lose its patent ...

Patients in Canada may have to wait longer to access generic versions of Ozempic because of continuing delays in processing of new drug submissions at Health Canada, according to Swiss generic drug ...